» Articles » PMID: 18034461

Phosphorylation of the Beta2-adrenergic Receptor in Plasma Membranes by Intrinsic GRK5

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2007 Nov 24
PMID 18034461
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Characterization of the GRKs participating in the phosphorylation of the beta2-adrenergic receptor (beta2AR) have in part been limited by the lack of a simple cell-free assay with membrane-bound beta2AR and GRKs. We describe here a cell-free assay for GRK phosphorylation of the beta2AR in a postnuclear 600g fraction and washed membranes by intrinsic GRK activity using the GRK phosphosite-specific antibody that recognizes pS(355,356). Treatment of these cell-free preparations with 1.0 microM isoproterenol (ISO) caused a rapid maximal 10-15-fold increase in GRK site phosphorylation of the beta2AR (t1/2 = 1 min) with an EC50 for ISO stimulation of approximately 80 nM. Extensively washed plasma membrane fractions retained the 10-15-fold ISO stimulation of GRK site phosphorylation and GRK5 levels while being depleted of GRK2 and GRK6. Stimulation of GRK site phosphorylation by a range of partial agonists correlated well with their intrinsic efficacy for stimulation of adenylyl cyclase. GRK phosphorylation of the beta2AR in the washed membrane fraction caused minimal desensitization of ISO stimulation of adenylyl cyclase activity. Association of GRK5 with the beta2AR in intact cells was demonstrated by a high level of basal BRET2 using beta2AR-Rluc and GRK5-GFP2 that was not diminished by agonist stimulation. BRET2 between the beta2AR-Rluc and GFP2-betaarrestin 2 was increased by agonist, whereas BRET2 between the beta2AR and GRK2-GFP2 was not significant. On the basis of the level of GRK5-mediated phosphorylation we observe in isolated membrane fractions and co-localization of the beta2AR and GRK5, we conclude that GRK5 plays a distinctive role in the phosphorylation of the beta2AR.

Citing Articles

BRET-Based Biosensors to Measure Agonist Efficacies in Histamine H Receptor-Mediated G Protein Activation, Signaling and Interactions with GRKs and β-Arrestins.

Verweij E, Bosma R, Gao M, van den Bor J, Al Araaj B, de Munnik S Int J Mol Sci. 2022; 23(6).

PMID: 35328605 PMC: 8953162. DOI: 10.3390/ijms23063184.


A Platelet Function Modulator of Thrombin Activation Is Causally Linked to Cardiovascular Disease and Affects PAR4 Receptor Signaling.

Rodriguez B, Bhan A, Beswick A, Elwood P, Niiranen T, Salomaa V Am J Hum Genet. 2020; 107(2):211-221.

PMID: 32649856 PMC: 7413854. DOI: 10.1016/j.ajhg.2020.06.008.


Differential Role of Serines and Threonines in Intracellular Loop 3 and C-Terminal Tail of the Histamine H Receptor in β-Arrestin and G Protein-Coupled Receptor Kinase Interaction, Internalization, and Signaling.

Verweij E, Al Araaj B, Prabhata W, Prihandoko R, Nijmeijer S, Tobin A ACS Pharmacol Transl Sci. 2020; 3(2):321-333.

PMID: 32296771 PMC: 7155198. DOI: 10.1021/acsptsci.0c00008.


Therapeutic Targets for Treatment of Heart Failure: Focus on GRKs and β-Arrestins Affecting βAR Signaling.

Mangmool S, Parichatikanond W, Kurose H Front Pharmacol. 2018; 9:1336.

PMID: 30538631 PMC: 6277550. DOI: 10.3389/fphar.2018.01336.


Genetic Determinants of Type 2 Diabetes in Asians.

Qi Q, Wang X, Strizich G, Wang T Int J Diabetol Vasc Dis Res. 2016; 2015(Suppl 1).

PMID: 27583258 PMC: 5003525. DOI: 10.19070/2328-353X-SI01001.